ENOSF1: The Potential Drug Target and Biomarker (G55556)

Target Name: ENOSF1

NCBI ID: G55556

ENOSF1

ENOSF1: The Potential Drug Target and Biomarker

ENOSF1 (endosomal protein of the secretory pathway 1) is a protein that plays a crucial role in the endosomal system, which is responsible for the delivery of proteins to various cell types. ENOSF1 is expressed in many different tissues and cells in the body, including the brain, heart, and gastrointestinal tract. Its function is not well understood, but it is known to be involved in the regulation of intracellular signaling pathways, which are important for many cellular processes.

The search for potential drug targets and biomarkers is an ongoing process in the field of drug development. These targets and biomarkers can provide valuable information about the underlying disease and are useful for the development of new treatments. ENOSF1 may be a drug target or biomarker due to its involvement in intracellular signaling pathways and its potential role in the development and progression of various diseases.

Drug Targets

ENOSF1 has been identified as a potential drug target due to its involvement in intracellular signaling pathways. ENOSF1 has been shown to play a role in the regulation of the PI3K/Akt signaling pathway, which is involved in many cellular processes, including cell survival, migration, and invasion.

The PI3K/Akt signaling pathway is a complex protein that is involved in the regulation of cellular signaling pathways. This pathway is known to be involved in the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

ENOSF1 has been shown to be involved in the regulation of the PI3K/Akt signaling pathway by participating in the formation of the endosomal system. The endosomal system is responsible for the delivery of intracellular proteins to various cell types, and ENOSF1 is involved in the delivery of proteins to the endosomal system.

Research has shown that ENOSF1 plays a role in the regulation of the PI3K/Akt signaling pathway by increasing the activity of the protein TrkB, which is a key regulator of the PI3K/Akt pathway. TrkB is known to be involved in the regulation of many cellular processes, including cell survival, migration, and invasion.

Biomarkers

ENOSF1 may also be used as a biomarker for the diagnosis and monitoring of certain diseases. Its involvement in intracellular signaling pathways makes it an attractive target for the development of new diagnostic tools and therapies.

ENOSF1 has been shown to be involved in the regulation of many cellular processes, including the regulation of cell adhesion, migration, and invasion. Its involvement in these processes makes ENOSF1 an attractive biomarker for the diagnosis and monitoring of certain diseases, such as cancer, neurodegenerative diseases, and autoimmune diseases.

Conclusion

ENOSF1 is a protein that has been shown to play a role in the regulation of intracellular signaling pathways and has been identified as a potential drug target and biomarker. Further research is needed to fully understand its function and its potential as a drug target and biomarker.

ENOSF1 may be a promising drug target and biomarker due to its involvement in intracellular signaling pathways and its potential role in the development and progression of various diseases. Further research is needed to fully understand its function and its potential as a drug target and biomarker.

Protein Name: Enolase Superfamily Member 1

Functions: Plays a role in the catabolism of L-fucose, a sugar that is part of the carbohydrates that are attached to cellular glycoproteins. Catalyzes the dehydration of L-fuconate to 2-keto-3-deoxy-L-fuconate by the abstraction of the 2-proton to generate an enediolate intermediate that is stabilized by the magnesium ion (PubMed:24697329)

The "ENOSF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ENOSF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets